References
- Podolsky DK. Inflammatory bowel disease. N. Engl. J. Med.347, 417–429 (2002).
- Tobin MV, Logan RF, Langman MJ, McConnell RB, Gilmore IT. Cigarette smoking and inflammatory bowel disease. Gastroenterology93(2), 316–321 (1987).
- Logan RF, Kay CR. Oral contraception, smoking and inflammatory bowel disease – findings in the Royal College of General Practitioners Oral Contraception Study. Int. J. Epidemiol.18(1), 105–107 (1989).
- Halfvarson J, Jess T, Magnuson A et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm. Bowel Dis.12(10), 925–933 (2006).
- Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology126(6), 1504–1517 (2004).
- Galluzzi L, Kepp O, Zitvogel L, Kroemer G. Bacterial invasion: linking autophagy and innate immunity. Curr Biol.20(3), R106–R108 (2010).
- Crohn BB, Ginzburg L, Oppenheimer GD. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. JAMA251, 73–79 (1984).
- Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology68, 627–635 (1975).
- Greenstein AJ, Lachman P, Sachar DB et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence of two clinical forms. Gut29, 588–592 (1988).
- Steinhart AH, Girgrah N, McLeod RS. Reliability of a Crohn’s disease clinical classification scheme based on disease behavior. Inflamm. Bowel Dis.4, 228–234 (1998).
- Gasche C, Scholmerich J, Brynskov J et al. A simple classification of Crohn‘s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm. Bowel Dis.6(1), 8–15 (2000).
- Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut55(6), 749–753 (2006).
- Chow DK, Leong RW, Lai LH et al. Changes in Crohn’s disease phenotype over time in the Chinese population: validation of the Montreal classification system. Inflamm. Bowel Dis.14(4), 536–541 (2008).
- Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn‘s disease activity index. National Cooperative Crohn‘s Disease Study. Gastroenterology70(3), 439–444 (1976).
- Singleton JW. Clinical activity assessment in inflammatory bowel disease. Dig. Dis. Sci.32(Suppl. 12), 42S–45S (1987).
- Yoshida EM. The Crohn’s Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: a review of instruments to assess Crohn’s disease. Can. J. Gastroenterol.13(1), 65–73 (1999).
- Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet1(8167), 514 (1980).
- Best WR. Predicting the Crohn’s disease activity index from the Harvey–Bradshaw Index. Inflamm. Bowel Dis.12(4), 304–310 (2006).
- van Hees PA, van Elteren PH, van Lier HJ, van Tongeren JH. An index of inflammatory activity in patients with Crohn’s disease. Gut21(4), 279–286 (1980).
- Truelove SC, Witts LF. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br. Med. J.2(4947), 1041–1048 (1955).
- Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. BMJ1(5375), 89–92 (1964).
- Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, Lennard-Jones JE. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig. Dis. Sci.27(6), 533–537 (1982).
- Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N. Engl. J. Med.317(26), 1625–1629 (1987).
- Lees CW, Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev. Gastroenterol. Hepatol.3(5), 513–534 (2009).
- Abraham C, Cho JH. Inflammatory bowel disease. N. Engl. J. Med.361(21), 2066–2078 (2009).
- Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet.40(8), 955–962 (2008).
- McGovern DP, Gardet A, Törkvist L et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet.42(4), 332–337 (2010).
- Hampe J, Grebe J, Nikolaus S et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn‘s disease: a cohort study. Lancet359(9318), 1661–1665 (2002).